Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233413 · ClinicalTrials.gov registry record · NA
Light Therapy for Moderate Traumatic Brain Injury
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT02233413: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02233413 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02233413, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if a specialized helmet that provides low levels of near infrared light, also known as low-level light therapy (LLLT) has any effect on the recovery of people who have recently (within 72h) suffered a moderate traumatic brain injury (TBI).
Interventions
- DEVICE Active LLLT helmet application
- DEVICE Non-active LLLT helmet application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2014-06 |
| Est. Completion | 2020-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02233413
The ClinicalTrials.gov registry entry for NCT02233413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active LLLT helmet application is the first listed.
NCT02233413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02233413 about?
NCT02233413 is a clinical study titled "Light Therapy for Moderate Traumatic Brain Injury". The purpose of this research study is to find out if a specialized helmet that provides low levels of near infrared light, also known as low-level light therapy (LLLT) has any effect on the recovery of people who have recently (within 72h) suffered a moderate traumatic brain injury (TBI).
What is the current status of trial NCT02233413?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2014-06. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02233413?
The interventions under investigation include: Active LLLT helmet application (DEVICE), Non-active LLLT helmet application (DEVICE).
Who is sponsoring clinical trial NCT02233413?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.